Ischemia-Modified Albumin Predicts Mortality in ESRD

Background: The primary study aim is to determine whether ischemia-modified albumin (IMA) levels predict mortality in patients with end-stage renal disease (ESRD). The secondary aim is to determine characteristics of patients with elevated IMA levels. Methods: A prospective observational study of 11...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2006-03, Vol.47 (3), p.493-502
Hauptverfasser:	Sharma, Rajan, Gaze, David C., Pellerin, Denis, Mehta, Rajnikant L., Gregson, Helen, Streather, Christopher P., Collinson, Paul O., Brecker, Stephen J.D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Biomarkers - blood end-stage renal disease (ESRD) Female Humans Ischemia-modified albumin Kidney Failure, Chronic - blood Kidney Failure, Chronic - complications Kidney Failure, Chronic - mortality Male Medical sciences Middle Aged mortality Myocardial Ischemia - blood Myocardial Ischemia - etiology Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Predictive Value of Tests Prospective Studies Renal failure renal transplantation candidate risk stratification Serum Albumin - analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!